Showing results (311-320 of 861) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|December 17, 2024
Setting "cold" tumors on fire: Cancer therapy with live tumor-targeting bacteriaSimin Manole, Dinh-Huy Nguyen, Jung-Joon Min, et al.Med (New York, N.Y.)|December 14, 2024
Ticagrelor monotherapy after short DAPT in ACS: Time to turn theory into practiceMattia Galli, Sebastiano SciarrettaMed (New York, N.Y.)|December 14, 2024
At the right time: Moving precision therapy to newly diagnosed cancerAdam Wahida, Ben George, Razelle KurzrockMed (New York, N.Y.)|February 15, 2025
Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fractionKristian Hellenkamp, Ryosuke Sato, Stephan von HaehlingMed (New York, N.Y.)|February 26, 2025
Ultra-rapid droplet digital PCR enables intraoperative tumor quantificationZachary R Murphy, Emilia C Bianchini, Andrew Smith, et al.Med (New York, N.Y.)|March 15, 2025
Integrating immunotherapy in the treatment of resectable gastric cancer: Are we on the right track?Roberto Pazo-Cid, Paula Gomila PonsMed (New York, N.Y.)|January 11, 2025
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedsideFlorent Peyraud, Jean-Philippe Guegan, Lucile Vanhersecke, et al.Med (New York, N.Y.)|January 11, 2025
Integrating CTLA-4/PD-1 blockade into cervical cancer management: Results of COMPASSION-16Jeffrey A How, Amir A JazaeriMed (New York, N.Y.)|January 11, 2025
Clinical advances of mRNA vaccines for cancer immunotherapyAlexey V Yaremenko, Muhammad Muzamil Khan, Xueyan Zhen, et al.Med (New York, N.Y.)|January 11, 2025
The climb toward intracranial efficacy: Zorifertinib in EGFR-mutant NSCLC with CNS metastases in the EVEREST trialMeaghan Roy-O'Reilly, David RogawskiPageof 87